CMG Pharmaceutical Co. Ltd Net Asset Quality Index
CMG Pharmaceutical Co. Ltd net asset quality index. CMG Pharmaceutical Co. Ltd (058820) has a Net Asset Quality Index of 65.9% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ₩305.96 Billion minus total liabilities of ₩104.41 Billion yields net assets of ₩201.55 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See 058820 net assets for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of CMG Pharmaceutical Co. Ltd (2011–2025)
Net asset quality index of CMG Pharmaceutical Co. Ltd from 2011 to 2025. This chart shows how CMG Pharmaceutical Co. Ltd's Net Asset Quality Index has evolved across 15 annual periods from 2011 to 2025. As of December 2025, the index stands at 65.9%, representing net assets of ₩201.55 Billion against total assets of ₩305.96 Billion KRW. Check 058820 strategic asset allocation to assess the company's strategic physical and investment asset allocation.
CMG Pharmaceutical Co. Ltd Net Asset Quality Index by Year (2011–2025)
CMG Pharmaceutical Co. Ltd net asset quality index by year from 2011 to 2025. The table below presents the year-by-year Net Asset Quality Index for CMG Pharmaceutical Co. Ltd from 2011 to 2025, covering 15 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 058820 market cap.
| Year | Quality Index | Net Assets (KRW) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 65.9% | ₩201.55 Billion | ₩305.96 Billion | ₩104.41 Billion | ▲ +3.4 pp |
| 2024 | 62.5% | ₩189.54 Billion | ₩303.44 Billion | ₩113.89 Billion | ▼ -16.1 pp |
| 2023 | 78.6% | ₩190.23 Billion | ₩242.10 Billion | ₩51.87 Billion | ▼ -8.1 pp |
| 2022 | 86.7% | ₩184.95 Billion | ₩213.26 Billion | ₩28.31 Billion | ▼ -6.0 pp |
| 2021 | 92.7% | ₩184.70 Billion | ₩199.17 Billion | ₩14.47 Billion | ▲ +0.0 pp |
| 2020 | 92.7% | ₩181.13 Billion | ₩195.36 Billion | ₩14.22 Billion | ▼ -1.0 pp |
| 2019 | 93.7% | ₩180.16 Billion | ₩192.24 Billion | ₩12.08 Billion | ▲ +2.8 pp |
| 2018 | 90.9% | ₩103.98 Billion | ₩114.38 Billion | ₩10.40 Billion | ▲ +1.5 pp |
| 2017 | 89.4% | ₩97.94 Billion | ₩109.57 Billion | ₩11.62 Billion | ▼ -1.7 pp |
| 2016 | 91.1% | ₩101.11 Billion | ₩110.98 Billion | ₩9.87 Billion | ▲ +8.3 pp |
| 2015 | 82.8% | ₩46.81 Billion | ₩56.53 Billion | ₩9.73 Billion | ▼ -1.6 pp |
| 2014 | 84.4% | ₩49.00 Billion | ₩58.07 Billion | ₩9.07 Billion | ▼ -3.2 pp |
| 2013 | 87.6% | ₩49.00 Billion | ₩55.91 Billion | ₩6.92 Billion | ▲ +32.3 pp |
| 2012 | 55.3% | ₩31.59 Billion | ₩57.11 Billion | ₩25.52 Billion | ▼ -10.7 pp |
| 2011 | 66.0% | ₩18.03 Billion | ₩27.31 Billion | ₩9.27 Billion | — |